Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX9BCU
|
||||
| Drug Name |
(1R)-1-(2-((S)-4-(6-cyanonaphthalen-1-yl)-2-methylpiperazin-1-yl)ethyl)-1,3,7,7a-tetrahydroisobenzofuran-5-carboxamide
|
||||
| Synonyms |
CHEMBL392780
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H30N4O2
|
||||
| Canonical SMILES |
C[C@H]1CN(CCN1CC[C@H]2OCC3=CC(=CCC23)C(=O)N)c4cccc5cc(ccc45)C#N
|
||||
| InChI |
InChI=1S/C27H30N4O2/c1-18-16-31(25-4-2-3-20-13-19(15-28)5-7-23(20)25)12-11-30(18)10-9-26-24-8-6-21(27(29)32)14-22(24)17-33-26/h2-7,13-14,18,24,26H,8-12,16-17H2,1H3,(H2,29,32)/t18-,24?,26+/m0/s1
|
||||
| InChIKey |
RNYOAQVTXKPTQL-XDYZAOKASA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1B receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.